Internet of Things (IoT)-Based Dialysis Machine Market Report 2026

The IoT-based dialysis machine market size has grown rapidly in recent years. It will grow from $1.75 billion in 2025 to $2.04 billion in 2026 at a compound annual growth rate (CAGR) of 16.8%. The growth in the historic period can be attributed to rising prevalence of chronic kidney disease, growing adoption of home-based dialysis, increasing demand for remote patient monitoring, expansion of digital health infrastructure, and rising healthcare expenditure on renal care.

The IoT-based dialysis machine market size is expected to see rapid growth in the next few years. It will grow to $3.76 billion in 2030 at a compound annual growth rate (CAGR) of 16.5%. The growth in the forecast period can be attributed to increasing penetration of iot-enabled medical devices, growing preference for home and portable dialysis solutions, rising adoption of telehealth and connected care, expansion of value-based renal care models,and increasing government support for digital healthcare. Major trends in the forecast period include technology advancements in connected dialysis systems, innovations in sensor-based real-time monitoring, developments in artificial intelligence and data analytics, research and development of portable and wearable dialysis devices, and integration of cloud platforms and electronic health records.

The increasing prevalence of chronic kidney disease is expected to drive the growth of the Internet of Things (IoT)-based dialysis machine market in the coming years. Chronic kidney disease is a long-term condition in which the kidneys gradually lose their ability to function effectively, resulting in the buildup of waste products and excess fluids in the body. The rise in chronic kidney disease is largely attributed to the growing incidence of diabetes and high blood pressure, as these conditions progressively damage kidney blood vessels and reduce the kidneys’ capacity to filter waste. IoT-based dialysis machines support the management of chronic kidney disease by enabling real-time monitoring of treatment parameters and patient vital signs through remote data connectivity. These systems improve patient outcomes by facilitating personalized therapy adjustments, early identification of complications, and more efficient long-term care. For example, in June 2023, according to Kidney Research UK, a UK-based nonprofit organization, around 7.2 million people in the United Kingdom were living with chronic kidney disease, accounting for over 10% of the population, with approximately 3.25 million in advanced stages and 3.9 million in early stages, and the total number of affected individuals projected to increase to 7.61 million by 2033. As a result, the rising prevalence of chronic kidney disease is contributing to the expansion of the IoT-based dialysis machine market.

Major participants in the Internet of Things (IoT)-based dialysis machine market are concentrating on the development of advanced solutions, such as connected home hemodialysis systems, to expand patient access and improve treatment adherence. Connected home hemodialysis systems incorporate smart software that guides patients through setup and treatment procedures, reducing the learning curve and enabling remote oversight by healthcare professionals, thereby increasing patient confidence and independence in managing kidney failure at home. For example, in September 2024, Fresenius Medical Care, a Germany-based healthcare company, introduced the NxStage VersiHD with GuideMe Software. This platform is designed to simplify connected home hemodialysis by offering visual guidance and user-friendly learning features, allowing patients to complete training 7 to 10 days faster than with conventional approaches. The solution also includes connectivity features that support a network of more than 14,000 patients in the United States, helping accelerate the adoption of home-based therapies and enhance the overall user experience for individuals requiring long-term renal replacement therapy.

In July 2025, Vantive Medical Technologies LLC, a US-based innovator in home dialysis systems, entered into a partnership with Innovative Renal Care Inc. to strengthen the use of technology in expanding home dialysis therapies. Through this collaboration, Vantive Medical Technologies LLC and Innovative Renal Care Inc. plan to integrate connected digital tools, remote monitoring, and IoT-enabled device capabilities into home dialysis workflows to enhance patient outcomes, support care teams, and enable more personalized therapy management. Innovative Renal Care Inc. is a US-based provider of comprehensive end-to-end kidney care services.

Major companies operating in the internet of things (iot)-based dialysis machine market are Medtronic plc, Fresenius Medical Care AG & Co. KGaA, Toray Industries Inc., Toray Medical Co. Ltd., Baxter International Inc., B. Braun Melsungen AG, Nipro Corporation, Wego Group, Bellco S.p.A., Mar Cor Purification, Mozarc Medical Holding LLC, Poly Medicure Limited, Outset Medical Inc., Quanta Dialysis Technologies Ltd., Infomed SA, Allmed Medical Care Holdings Limited, Innovative Renal Care, Gambro, Nextkidney BV, Newsol Technologies.

North America was the largest region in the IoT-based dialysis machine market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the internet of things (iot)-based dialysis machine market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the internet of things (iot)-based dialysis machine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs are impacting the iot-based dialysis machine market by increasing costs of imported sensors, connectivity modules, embedded electronics, cloud infrastructure hardware, and precision medical components. hospitals and dialysis centers in north america and europe are most affected due to reliance on imported high-value medical electronics, while asia-pacific faces cost pressures on export-oriented device manufacturing. these tariffs are raising system procurement costs and slowing large-scale deployments. however, they are also encouraging localized manufacturing, regional sourcing of electronic components, and domestic development of connected dialysis platforms.

Internet of Things (IoT)-based dialysis machines are dialysis systems embedded with IoT technologies that allow real-time data capture, remote monitoring, automated control, and intelligent decision support throughout dialysis treatment. These systems utilize connected sensors, cloud computing, wireless connectivity, and data analytics to continuously monitor patient parameters such as blood pressure, flow rates, ultrafiltration volume, and equipment performance. Their objective is to enhance treatment precision, improve patient safety, enable predictive maintenance, and support personalized dialysis care while lowering clinical workload.

The primary components of IoT-based dialysis machines include hardware, software, services, and consumables. Hardware consists of connected dialysis machines and embedded sensors that enable real-time monitoring and automated therapy adjustments. Product types include IoT-enabled hemodialysis systems, IoT-enabled peritoneal dialysis machines, portable and wearable devices, software platforms, and related consumables. Connectivity options include Wi-Fi, cellular networks, cloud analytics, and decision-support modules, used in chronic kidney disease care, end-stage renal disease, acute kidney injury, and remote monitoring, across hospitals, dialysis centers, home care, ambulatory centers, and specialty clinics.

The internet of things (IoT)-based dialysis machine market includes revenues earned by entities through remote patient monitoring, real-time machine performance tracking, predictive maintenance, treatment data analytics, automated alerts for anomalies, telehealth integration, and personalized dialysis therapy management. The market value includes the value of hardware, embedded software, connectivity solutions, and associated digital health platforms sold by manufacturers or incorporated into dialysis service offerings. Only goods and services traded between entities or sold to end users such as hospitals, dialysis centers, and home-care providers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.